Home/Pipeline/CAR-NK-based Cell Therapy

CAR-NK-based Cell Therapy

Liver Cancer (Hepatocellular Carcinoma)

Pre-clinicalActive

Key Facts

Indication

Liver Cancer (Hepatocellular Carcinoma)

Phase

Pre-clinical

Status

Active

Company

IO Biosciences

About IO Biosciences

iO BiO Sciences is a private, preclinical-stage biotech founded in 2015 and based in Rockville, Maryland. The company is pioneering a versatile platform technology, GEMS™, designed to overcome key manufacturing and scalability challenges in cell and gene therapy. Its primary application is the creation of universal, engineered NK cell therapies for oncology, aiming to provide more accessible and cost-effective treatments compared to autologous approaches. Led by founder and CEO Sicco Popma, PhD, a veteran of Janssen/J&J cell therapy development, the company is positioned to advance its pipeline and seek partnerships.

View full company profile

Therapeutic Areas

Oncology

Other Liver Cancer (Hepatocellular Carcinoma) Drugs

Drug	Company	Phase	Status
AU-409	Auransa	Phase 1	First-in-human trial ongoing in US; first patient dosed in Asia
Oncolytic VSV for Liver Cancer	Humane Genomics	Preclinical	Active